Switch to:
More From Other Websites
Early movers: HAS, BBT, GIS, T, NAV, CBS & more Sep 02 2015
Sept. 2 Premarket Briefing: 10 Things You Should Know Sep 02 2015
Amgen and UCB's Osteoporosis Drug Bests Lilly's Forteo in Study Sep 02 2015
Novartis, Amgen partner on Alzheimer's, migraine treatment Sep 02 2015
Novartis, Amgen partner on Alzheimer's, migraine treatment Sep 02 2015
Business Watch Sep 01 2015
Amgen and Novartis partnering on a drug that could prevent Alzheimer's Sep 01 2015
After-hours buzz: H&R Block, Anheuser-Busch & more Sep 01 2015
Valeant steps in to work on psoriasis drug with AstraZeneca Sep 01 2015
Valeant steps in to work on psoriasis drug with AstraZeneca Sep 01 2015
Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs Sep 01 2015
Amgen's bone drug succeeds in late-stage study Sep 01 2015
Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine... Sep 01 2015
Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine... Sep 01 2015
Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab... Sep 01 2015
4:03 pm Amgen and UCB announce positive top-line results from their open-label phase 3 study of... Sep 01 2015
Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab... Sep 01 2015
Gilead Sciences: Most Enticing Sep 01 2015
Amgen finds data falsified in obesity-diabetes study featuring grizzly bears Sep 01 2015
Amgen Finds Data Falsified in Obesity-Diabetes Study Featuring Grizzly Bears Sep 01 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK